Pathogenesis of fibrosis: type 1 collagen and the skin - PubMed (original) (raw)

Review

. 1998 Mar;76(3-4):266-74.

doi: 10.1007/s001090050216.

Affiliations

• PMID: 9535560
• DOI: 10.1007/s001090050216

Review

Pathogenesis of fibrosis: type 1 collagen and the skin

M Trojanowska et al. J Mol Med (Berl). 1998 Mar.

Abstract

This review on the pathogenesis of fibrosis emphasizes the similarities between tissue repair, a tightly regulated salutary biological response, and fibrosis, an unregulated pathological process. It focuses on the transcriptional regulation of type I collagen, the role of cytokines in fibroblast activation, integrins as examples of cell-matrix signaling pathways, and the heterogeneity of fibroblast populations as factors contributing to fibrosis. Tissue remodeling and the role of matrix metalloproteinases and metalloproteinase inhibitors are mentioned briefly. The capacity of extracellular matrix to modulate cellular function is a recurring theme.

PubMed Disclaimer

Similar articles

• Pathogenesis of scleroderma. Collagen.
  Jimenez SA, Hitraya E, Varga J. Jimenez SA, et al. Rheum Dis Clin North Am. 1996 Nov;22(4):647-74. doi: 10.1016/s0889-857x(05)70294-5. Rheum Dis Clin North Am. 1996. PMID: 8923589 Review.
• Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity.
  Cook H, Davies KJ, Harding KG, Thomas DW. Cook H, et al. J Invest Dermatol. 2000 Aug;115(2):225-33. doi: 10.1046/j.1523-1747.2000.00044.x. J Invest Dermatol. 2000. PMID: 10951240
• Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis.
  Mauch C, Kreig T. Mauch C, et al. Rheum Dis Clin North Am. 1990 Feb;16(1):93-107. Rheum Dis Clin North Am. 1990. PMID: 2406813 Review.
• Factors involved in the regulation of type I collagen gene expression: implication in fibrosis.
  Ghosh AK. Ghosh AK. Exp Biol Med (Maywood). 2002 May;227(5):301-14. doi: 10.1177/153537020222700502. Exp Biol Med (Maywood). 2002. PMID: 11976400 Review.

Cited by

• Pyrroloquinoline quinone ameliorates PM2.5-induced pulmonary fibrosis through targeting epithelial-mesenchymal transition.
  Chao CC, Hsiao SY, Kao WC, Chiou PC, Huang CC, Wang MT, Chen PC. Chao CC, et al. J Cell Mol Med. 2024 Apr;28(8):e18299. doi: 10.1111/jcmm.18299. J Cell Mol Med. 2024. PMID: 38613355 Free PMC article.
• Standardizing urethral stricture models in rats: a comprehensive study on histomorphologic and molecular approach.
  Ergün O, Tepebaşi MY, Onaran İ, Öztürk SA, Baltik M, Koşar PA. Ergün O, et al. Int Urol Nephrol. 2024 Sep;56(9):2945-2954. doi: 10.1007/s11255-024-04034-4. Epub 2024 Apr 2. Int Urol Nephrol. 2024. PMID: 38564077
• Antifibrotic Effect of Selenium-Containing Nanoparticles on a Model of TAA-Induced Liver Fibrosis.
  Varlamova EG, Goltyaev MV, Rogachev VV, Gudkov SV, Karaduleva EV, Turovsky EA. Varlamova EG, et al. Cells. 2023 Nov 28;12(23):2723. doi: 10.3390/cells12232723. Cells. 2023. PMID: 38067151 Free PMC article.
• Topical Administration of an Apoptosis Inducer Mitigates Bleomycin-Induced Skin Fibrosis.
  Huda MN, Borrego EA, Guerena CD, Varela-Ramirez A, Aguilera RJ, Hamadani CM, Tanner EEL, Badruddoza AZM, Agarwal SK, Nurunnabi M. Huda MN, et al. ACS Pharmacol Transl Sci. 2023 Apr 28;6(5):829-841. doi: 10.1021/acsptsci.3c00039. eCollection 2023 May 12. ACS Pharmacol Transl Sci. 2023. PMID: 37200808 Free PMC article.
• Application of nanoparticles in the diagnosis and treatment of chronic kidney disease.
  Yang K, Shang Y, Yang N, Pan S, Jin J, He Q. Yang K, et al. Front Med (Lausanne). 2023 Apr 17;10:1132355. doi: 10.3389/fmed.2023.1132355. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37138743 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations